Patents by Inventor Stephen L. Hauser

Stephen L. Hauser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PERSONALIZED CONTEXTUALIZATION OF PATIENT TRAJECTORY
    Publication number: 20200312429
    Abstract: Methods, apparatuses, and systems are provided for creating and using a database to identify reference patient data to compare to a current patient. The data can be stored per patient visit, where such a measurement record can store information about the patient, such as a measurement value for a severity of a disease. Data for each patient visit can be accessed separately. A user interface for accessing the database can be configured in a user-friendly manner to allow a user to specify one or more filtering criteria. For example, a user can specify a filtering criterion for reference data to be displayed for a given measurement value of a disease at a particular time (e.g., duration of a disease), and have other filter criteria automatically generated to be applied to reference data at other times.
    Type: Application
    Filed: June 22, 2017
    Publication date: October 1, 2020
    Applicant: The Regents of the University of California
    Inventors: Pierre-Antoine Gourraud, Antoine Lizée, Stephen L. Hauser
  • Identifying High Risk Clinically Isolated Syndrome Patients
    Publication number: 20110281750
    Abstract: Disclosed herein are methods and kits for identifying clinically isolated syndrome (CIS) patients at high risk of developing multiple sclerosis (MS).
    Type: Application
    Filed: July 24, 2009
    Publication date: November 17, 2011
    Applicant: The Regents of the University of California, a California Corporation
    Inventors: Jean-Christophe Corvol, Daniel Pelletier, Stephen L. Hauser, Jorge R. Oksenberg, Sergio Baranzini
  • Inhibiting MOG-antibody binding
    Patent number: 6573236
    Abstract: The invention provides methods and compositions for inhibiting pathogenic binding of an pathogenic autoantibody to a myelin oligodendrocyte glycoprotein (MOG) autoantigen and screening for inhibitors of pathogenic binding of an autoantibody to a MOG autoantigen.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: June 3, 2003
    Assignee: The Regents of the University of California
    Inventors: Claude P. Genain, Stephen L. Hauser
  • Recombinant antibody fragments as autoantibody antagonists
    Patent number: 6569431
    Abstract: The invention provides methods and compositions for inhibiting autoantibody binding in demyelinating disease such as multiple sclerosis. The compositions comprise immunoglobulin CDR3 sequences derived from combinatorial phage display libraries selected for high-affinity binding to myelin oligodendrocyte glycoprotein.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: May 27, 2003
    Assignee: The Regents of the University of California
    Inventors: Hans-Christian von Büdingen, Claude P. Genain, Stephen L. Hauser
  • Recombinant antibody fragments as autoantibody antagonists
    Publication number: 20020072588
    Abstract: The invention provides methods and compositions for inhibiting autoantibody binding in demyelinating disease such as multiple sclerosis. The compositions comprise immunoglobulin CDR3 sequences derived from combinatorial phage display libraries selected for high-affinity binding to myelin oligodendrocyte glycoprotein.
    Type: Application
    Filed: July 5, 2001
    Publication date: June 13, 2002
    Inventors: Hans-Christian von Budingen, Claude P. Genain, Stephen L. Hauser
  • Autoantibody inhibitors
    Publication number: 20020068058
    Abstract: The invention provides methods and compositions for inhibiting pathogenic binding of an pathogenic autoantibody to a myelin oligodendrocyte glycoprotein (MOG) autoantigen and screening for inhibitors of pathogenic binding of an autoantibody to a MOG autoantigen.
    Type: Application
    Filed: December 21, 2001
    Publication date: June 6, 2002
    Inventors: Claude P. Genain, Stephen L. Hauser
  • Autoantibody inhibitors
    Patent number: 6333033
    Abstract: The invention provides methods and compositions for inhibiting pathogenic binding of an pathogenic autoantibody to a myelin oligodendrocyte glycoprotein (MOG) autoantigen and screening for inhibitors of pathogenic binding of an autoantibody to a MOG autoantigen.
    Type: Grant
    Filed: August 26, 1999
    Date of Patent: December 25, 2001
    Assignee: The Regents of the University of California
    Inventors: Claude P. Genain, Stephen L. Hauser